DOXOrubicin

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91395 publications

Efficacy and safety of trabectedin and pegylated liposomal doxorubicin in elderly patients: a subgroup analysis of a retrospective cohort.

Efficacy and safety of trabectedin and pegylated liposomal doxorubicin in elderly patients: a subgroup analysis of a retrospective cohort.

Journal: Journal of chemotherapy (Florence, Italy)
Published: January 23, 2026

Systemic treatment of bone sarcoma, soft tissue sarcoma, GIST

Systemic treatment of bone sarcoma, soft tissue sarcoma, GIST

Journal: La Revue du praticien
Published: January 23, 2026

Target Identification of the Hepatocellular Carcinoma-Specific Aptamer JHIT2e and Construction of Engineered Nanotrains for Synergistic Chemoradiotherapy.

Target Identification of the Hepatocellular Carcinoma-Specific Aptamer JHIT2e and Construction of Engineered Nanotrains for Synergistic Chemoradiotherapy.

Journal: Molecular pharmaceutics
Published: January 23, 2026

Patient-derived osteosarcoma tumouroid model reveals functional phenotypic diversity with implications for drug responses.

Patient-derived osteosarcoma tumouroid model reveals functional phenotypic diversity with implications for drug responses.

Journal: Biofabrication
Published: January 22, 2026

Dual NIR-I excitation and emission-based thermometry and pH-responsive drug delivery using NaYF4:Yb,Er@SiO2-folic acid conjugates.

Dual NIR-I excitation and emission-based thermometry and pH-responsive drug delivery using NaYF4:Yb,Er@SiO2-folic acid conjugates.

Journal: Journal of materials chemistry. B
Published: January 21, 2026

A superoxide anion radical-activatable Golgi-targeting prodrug-based albumin complex for synergistic chemo-immunotherapy of triple-negative breast cancer.

A superoxide anion radical-activatable Golgi-targeting prodrug-based albumin complex for synergistic chemo-immunotherapy of triple-negative breast cancer.

Journal: Journal of materials chemistry. B
Published: January 20, 2026

Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs.

Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs.

Journal: Biomacromolecules
Published: January 19, 2026

Peptide/Doxorubicin Co-Assembled Hydrogel for Hemostatic Control and Sustained Local Chemotherapy after Tumor Surgery.

Peptide/Doxorubicin Co-Assembled Hydrogel for Hemostatic Control and Sustained Local Chemotherapy after Tumor Surgery.

Journal: Molecular pharmaceutics
Published: January 19, 2026

Trisulfide-Bridged Polymer-Drug Conjugates for Synergistic H2S and Doxorubicin Delivery.

Trisulfide-Bridged Polymer-Drug Conjugates for Synergistic H2S and Doxorubicin Delivery.

Journal: Biomacromolecules
Published: January 19, 2026

Cryopreservation technology for improving the stability of liposomes and its precise drug monitoring in clinical drug research.

Cryopreservation technology for improving the stability of liposomes and its precise drug monitoring in clinical drug research.

Journal: Drug delivery
Published: January 18, 2026

Two Suggestive Cases of Tumor Resection for Bowel Obstruction Due to Malignant Lymphoma of the Ileum

Two Suggestive Cases of Tumor Resection for Bowel Obstruction Due to Malignant Lymphoma of the Ileum

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026

Lauric acid mitigates doxorubicin-induced cardiotoxicity in rats: Modulation of oxidative stress and inflammation via NF-κB p65 attenuation.

Lauric acid mitigates doxorubicin-induced cardiotoxicity in rats: Modulation of oxidative stress and inflammation via NF-κB p65 attenuation.

Journal: Pakistan journal of pharmaceutical sciences
Published: January 17, 2026
Showing 1-12 of 91,395

Last Updated: 02/24/2026